COLOMBO, Gaia
 Distribuzione geografica
Continente #
NA - Nord America 9.110
AS - Asia 4.361
EU - Europa 3.028
SA - Sud America 990
AF - Africa 95
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 2
Totale 17.611
Nazione #
US - Stati Uniti d'America 8.936
SG - Singapore 1.751
CN - Cina 1.219
BR - Brasile 836
IT - Italia 703
UA - Ucraina 556
HK - Hong Kong 445
DE - Germania 372
TR - Turchia 311
GB - Regno Unito 290
VN - Vietnam 255
PL - Polonia 234
FR - Francia 180
SE - Svezia 172
RU - Federazione Russa 146
FI - Finlandia 136
MX - Messico 92
IN - India 84
ID - Indonesia 72
CA - Canada 70
AR - Argentina 64
ZA - Sudafrica 46
ES - Italia 45
NL - Olanda 45
JP - Giappone 34
GR - Grecia 29
EC - Ecuador 26
BD - Bangladesh 25
IR - Iran 25
PK - Pakistan 25
AT - Austria 21
BE - Belgio 19
IQ - Iraq 19
CO - Colombia 18
AU - Australia 17
IL - Israele 14
CH - Svizzera 13
TN - Tunisia 13
MY - Malesia 12
PE - Perù 12
LT - Lituania 11
PT - Portogallo 10
PY - Paraguay 10
VE - Venezuela 10
CL - Cile 9
EG - Egitto 9
KR - Corea 9
RO - Romania 9
NZ - Nuova Zelanda 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
MA - Marocco 7
JO - Giordania 6
TW - Taiwan 6
UZ - Uzbekistan 6
BG - Bulgaria 5
DZ - Algeria 5
IE - Irlanda 4
KE - Kenya 4
BO - Bolivia 3
DK - Danimarca 3
HU - Ungheria 3
JM - Giamaica 3
LB - Libano 3
NG - Nigeria 3
SA - Arabia Saudita 3
AL - Albania 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
BY - Bielorussia 2
EU - Europa 2
GA - Gabon 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
KG - Kirghizistan 2
KH - Cambogia 2
KZ - Kazakistan 2
LV - Lettonia 2
NP - Nepal 2
PS - Palestinian Territory 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
YE - Yemen 2
AM - Armenia 1
BN - Brunei Darussalam 1
BW - Botswana 1
CR - Costa Rica 1
CY - Cipro 1
GT - Guatemala 1
KW - Kuwait 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NI - Nicaragua 1
NO - Norvegia 1
Totale 17.600
Città #
Fairfield 998
Singapore 962
Woodbridge 956
Houston 697
Ashburn 695
Jacksonville 621
Chandler 545
Santa Clara 537
Ann Arbor 472
Hong Kong 427
Beijing 376
Wilmington 371
Seattle 366
Cambridge 328
Izmir 243
Warsaw 223
Nanjing 177
Princeton 153
Boardman 100
Los Angeles 94
Ho Chi Minh City 92
Ferrara 90
Dallas 79
San Diego 75
Shenyang 68
São Paulo 60
New York 59
Nanchang 53
Hanoi 51
Mexico City 48
Milan 45
Hebei 44
Tianjin 42
Jakarta 41
Shanghai 41
London 38
Mountain View 34
Redwood City 33
Hefei 31
Moscow 31
Rio de Janeiro 30
Falls Church 28
Jiaxing 28
Bremen 26
Munich 26
Rome 26
Addison 25
Chicago 23
Tokyo 23
Atlanta 22
Frankfurt am Main 21
Bologna 20
Brussels 19
Changsha 19
Poplar 19
Columbus 18
Parma 18
Zhengzhou 18
Brooklyn 17
Johannesburg 17
Falkenstein 16
Jinan 16
The Dalles 16
Haiphong 15
Norwalk 15
Belo Horizonte 14
Brasília 14
Denver 14
Orange 14
San Francisco 14
Helsinki 13
Nuremberg 13
Stockholm 13
Auburn Hills 12
Boston 12
Council Bluffs 12
Manchester 12
Philadelphia 12
Verona 12
Buffalo 11
Da Nang 11
Fortaleza 11
Hangzhou 11
Kunming 11
Naples 11
Ningbo 11
Phoenix 11
Vienna 11
Athens 10
Curitiba 10
Des Moines 10
Guangzhou 10
Guayaquil 10
Orem 10
Porto Alegre 10
Campinas 9
Florianópolis 9
Karachi 9
Lima 9
Montreal 9
Totale 11.312
Nome #
Studio di uno spray topico di sucralfato gel e cidofovir per la terapia antivirale di ovini 337
PRINCIPI DI CALCOLO FARMACEUTICO 295
In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates 294
Opportunity and challenges of nasal powders: Drug formulation and delivery 267
Biological In Vitro Models for Absorption by Nonoral Routes 249
Effect of residual water content on the physico-chemical properties of sucralfate dried gel obtained by microwave drying 225
The development of a single-use, capsule-free multi-breath tobramycin dry powder inhaler for the treatment of cystic fibrosis 221
Chimerical agglomerates of lecithin/chitosan nanoparticles for powder nasal delivery 218
Respiratory Drug Delivery 194
Design of experiments (DoE) in pharmaceutical development 185
Nasal powders of thalidomide for local treatment of nose bleeding in persons affected by hereditary hemorrhagic telangiectasia 183
Ex vivo permeation of tamoxifen and its 4-OH metabolite through rat intestine from lecithin/chitosan nanoparticles 183
Assemblage of Novel Release Modules for the Development of Adaptable Drug Delivery Systems 180
Bioadhesive sucralfate gel-based suspension containing cidofovir for spray treatment of viral infections in lamb and sheep 178
Brain Targeting of an Antiischemic Agent by Nasal Administration of Microparticles 178
Bioadhesive film for transdermal delivery of lidocaine: in vitro and in vivo behavior 175
Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients 171
Spray-dried amikacin sulphate powder for inhalation in cystic fibrosis patients: The role of ethanol in particle formation 165
Surface-modified nanocarriers for nose-to-brain delivery: From bioadhesion to targeting 163
Artesunate-clindamycin multi-kinetics and site-specific oral delivery system for antimalaric combination products 158
The use of fatty acids as absorption enhancer for pulmonary drug delivery 155
Skin permeation of 5-methoxypsoralen from topical dosage forms 153
Dry powder inhalers: An overview of the in vitro dissolution methodologies and their correlation with the biopharmaceutical aspects of the drug products 152
The Effect of Residual Water on Antacid Properties of Sucralfate Gel Dried by Microwaves 151
Bioencapsulation methods for cell inclusion in polysaccharidic matrices for clinical applications 150
Floating modular drug delivery systems with buoyancy independent of release mechanisms to sustain amoxicillin and clarithromycin intra-gastric concentrations 149
Swellable and Rigid Matrices: Controlled Release Matrices with Cellulose Ethers 147
null 147
Chitosan coated human serum albumin nanoparticles: A promising strategy for nose-to-brain drug delivery 147
Alginate and cell combination product for wound healing 146
Module assemblage technology for floating systems: in vitro flotation and in vivo gastro-retention 143
The suitability of disintegrating force kinetics for studying the effect of manufacturing parameters on spironolactone tablet properties 142
Novel Platforms for Oral Drug Delivery 142
Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease 141
Autoassembled nanoparticles of lecithin/chitosan for oral delivery of the anticancer drug tamoxifen citrate 137
Combination of alginate and cells for skin regeneration 136
In vitro and in vivo study of 5-methoxypsoralen skin concentration after topical application 134
From tablets to pharmaceutical nanotechnologies: Innovation in drug delivery strategies for the administration of antimalarial drugs 134
Soft Agglomerates of Pantoprazole Gastro-resistant Microparticles for Oral Administration and Intestinal Release 133
Therapeutic paint of cidofovir/sucralfate gel combination topically administered by spraying for treatment of orf virus infections 133
Prolongation of sciatic nerve blockade by in situ cross-linked hyaluronic acid 132
A Study for the Development of Mesalazine Multiparticulate Dosage Forms for Colon Delivery in Pediatric Patients 132
A Clinical Study of a Methacholine Dry Powder for the Bronchial Challenge Test 131
A new 5-methoxypsoralen formulation for the topical treatment of psoriasis 131
Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells 131
The formulation of a novel macrolide solution pressurised metered dose inhaler: the use of Clarithromycin as an anti-inflammatory for bronchiectasis therapy 128
Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats 128
Prolonged duration local anesthesia from tetrodotoxin-enhanced local anesthetic microspheres 128
Formulation Strategies for Antitubercular Drugs by Inhalation 128
Post-iontophoresis transport of ibuprofen lysine across rabbit ear skin 127
Mechanisms of formation and disintegration of alginate beads obtained by prilling 126
Nasal administration and brain targeting of an antiischemic agent 125
Prolonged duration local anesthesia with lipid-protein-sugar particles containing bupivacaine and dexamethasone 122
null 122
Methacholine dry powder inhaler as a new tool for bronchial challenge test 119
N6-cyclopentyladenosine : selective brain targeting by nasal administration of microparticles 117
Effect of excipient composition on the biocompatibility of bupivacaine-containing microparticles at the sciatic nerve 117
Prolonged duration local anesthesia with lipid-protein-sugar particles containing bupivacaine and dexamethasone 117
Geometric Release Systems: Principles, Release Mechanisms, Kinetics, Polymer Science, and Release-Modifying Material 116
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction 113
The role of dissolution test in a comparison of generic and branded controlled-release products 111
Single layer dermal patch: skin accumulation assessed by tape stripping 110
Efficacy and biocompatibility of bupivacaine-loaded lipid-protein-sugar particles for prolonged duration local anesthesia 107
null 106
Spray therapeutic paint for topical treatment of orf virus skin infections in breeding sheep 103
Brain Uptake of an Antiischemic Agent by Nasal Administration of Microparticles 103
Chitosan-coated nanoparticles: Effect of chitosan molecular weight on nasal transmucosal delivery 103
Therapeutic paint for simultaneous delivery of sucralfate gel and cidofovir in the treatment of veterinary viral skin infections 102
In vitro and in vivo study of a desmopressin nasal powder 101
null 101
Film for active ingredients dermal and transdermal administration 101
null 100
Aerodynamic assessment for inhalation products: fundamentals and current pharmacopoeial methods 99
Aerosolization performance of jet nebulizers and biopharmaceutical aspects 98
null 97
Diclofenamic acid-vitamin C conjugates: stability and interaction studies with ascorbate transporters 97
Progesterone-loaded lecithin/chitosan isopropylmyristate nanoparticles for transmucosal delivery 96
Enhancing ribavirin nose-to-brain delivery by powder formulation for veterinary CNS infections 96
null 96
Soft agglomerates containing microencapsulated levothyroxine for buccal or oral delivery 96
Multi-kinetics and site-specific release of gabapentin and flurbiprofen from oral fixed-dose combination: in vitro release and in vivo food effect 96
Soft chimera agglomerates for desmopressin nasal administration: an in vitro and in vivo study 95
Nasal powders of morphine microcrystals agglomerates 95
Strategies in bupivacaine delivery for prolonged duration local anesthesia 94
Study of a Sucralfate gel-based therapeutic paint for antiviral drug topical application by spraying 94
Ex vivo propofol permeation across nasal mucosa: A proof-of-concept study for outpatient light sedation via nasal route 93
Compositions in powder form made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation 93
Development of artemisinin - β-cyclodextrin complex agglomerates 93
In vitro transport studies across excised nasal mucosa for three drug candidates to nose-to-brain delivery 93
Development of a spray-dried powder for nasal administration of desmopressin acetate 92
PRODRUGS, MICRO OR NANOPARTICULATE SYSTEMS AND NASAL ADMNISTRATION AS NON INVASIVE APPROACHES AGAINST BRAIN DISEASES AND AIRBORNE INFECTIONS. LOCO-REGIONAL THERAPY OF CANCER 91
In vitro comparison of four anti-inflammatory topical medications 91
null 91
Nose-to-brain delivery of ribavirin (RBV) for the treatment of viral encephalitis 91
Construction of amikacin dry powders for inhalation by a Central Composite Design 91
Use of sucralfate gel as a vehicle for topical administration of the antiviral drug cidofovir 90
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: The enhancing effect of potassium sorbate 89
Flurbiprofen sodium microparticles and soft pellets for nose-to-brain delivery: Serum and brain levels in rats after nasal insufflation 89
Produzione e caratterizzazione di nanoparticelle ottenute dall'interazione ionica tra lecitina e chitosano 88
Desmopressin Dry Powder for Nasal Administration 88
Totale 13.441
Categoria #
all - tutte 79.302
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.067
Totale 83.369


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.185 0 0 0 0 0 151 182 210 74 280 188 100
2021/20221.265 51 154 98 66 55 76 44 76 41 101 118 385
2022/20231.299 164 54 27 159 238 193 34 127 167 15 86 35
2023/2024608 93 91 34 23 41 25 15 28 9 28 55 166
2024/20252.881 93 46 229 87 433 317 173 165 445 344 301 248
2025/20264.005 561 435 730 1.059 939 281 0 0 0 0 0 0
Totale 17.841